Topics

AIM ImmunoTech Inc: AIM ImmunoTech Issues Stockholder Update and Details Its Expectations for 2020

06:32 EST 4 Dec 2019 | FinanzNachrichten
Related Biotechnology, Pharmaceutical and Healthcare News

OCALA, FL / ACCESSWIRE / December 4, 2019 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers a...

Original Article: AIM ImmunoTech Inc: AIM ImmunoTech Issues Stockholder Update and Details Its Expectations for 2020

NEXT ARTICLE

More From BioPortfolio on "AIM ImmunoTech Inc: AIM ImmunoTech Issues Stockholder Update and Details Its Expectations for 2020"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored ND2A Group with offices at 677 Craig Rd, Suite 216, Creve Coeur, Missouri 63141 USA. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact ND2A Group.

All rights reserved. All other trademarks recognized. Copyright © 2019 ND2A Group. Site developed by Alacrify Ltd

.